Free Trial

Semler Scientific Inc. (NASDAQ:SMLR) Shares Acquired by GAMMA Investing LLC

Semler Scientific logo with Medical background

GAMMA Investing LLC raised its position in shares of Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 49,133.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,385 shares of the company's stock after acquiring an additional 7,370 shares during the quarter. GAMMA Investing LLC owned approximately 0.08% of Semler Scientific worth $267,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Principal Financial Group Inc. increased its holdings in shares of Semler Scientific by 633.1% in the fourth quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock valued at $6,074,000 after purchasing an additional 97,144 shares during the last quarter. IFP Advisors Inc acquired a new stake in shares of Semler Scientific in the fourth quarter valued at approximately $54,000. Wells Fargo & Company MN increased its holdings in shares of Semler Scientific by 618.3% in the fourth quarter. Wells Fargo & Company MN now owns 103,465 shares of the company's stock valued at $5,587,000 after purchasing an additional 89,060 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Semler Scientific by 11.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 48,625 shares of the company's stock valued at $2,626,000 after purchasing an additional 4,802 shares during the last quarter. Finally, Sanctuary Advisors LLC increased its holdings in shares of Semler Scientific by 13.2% in the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock valued at $261,000 after purchasing an additional 584 shares during the last quarter. Institutional investors and hedge funds own 49.37% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen cut Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd.

View Our Latest Research Report on SMLR

Semler Scientific Price Performance

NASDAQ:SMLR opened at $36.14 on Friday. Semler Scientific Inc. has a one year low of $21.77 and a one year high of $81.56. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.51 and a current ratio of 0.52. The stock has a market cap of $402.96 million, a PE ratio of -13.85 and a beta of 1.42. The stock has a 50 day moving average price of $35.37 and a 200 day moving average price of $44.48.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. The business had revenue of $8.84 million during the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.

Semler Scientific Profile

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Read More

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific Inc. (NASDAQ:SMLR - Free Report).

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Semler Scientific Right Now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines